This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Yan, Z.-q. Search for Related Content PubMed PubMed Citation Articles by Yan, Z.-q. Related Collections Related Articles

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2582.)
© 2006 American Heart Association, Inc.

Editorials

Regulation of TLR4 Expression Is a Tale About Tail

Zhong-qun Yan

From the Center for Molecular Medicine, Karolinska Institute, Sweden.

Correspondence to Zhong-qun Yan, Center for Molecular Medicine L8:03, Karolinska Institute, 171 76 Stockholm, Sweden. E-mail Zhong-qun.yan@ki.se

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Toll-like receptor (TLR) 4 is the first identified mamalian homolog of the Drosophila Toll protein.¹ TLR4 recognizes bacterial lipopolysaccharide (LPS), and also senses endogenous ligands including hyaluronic acid, oxidized low-density lipoprotein, and heat-shock proteins. Engagement of TLR4 with its ligand triggers a cascade of cellular signals through the intracellular signal transduction domain, known as Toll/interleukin (IL)-1 receptor (TIR), leading to the activation of nuclear factor-B (NF-B) and mitogen-activated protein kinase (MAPK) signal transduction pathways, consequently inducing expression of inflammatory genes.² Although the TLR family of molecules normally contributes to host defense, excess TLR signaling has been implicated in many inflammatory diseases. That TLR4 is implicated in cardiovascular diseases was first suggested by observations of increased expression of TLR4 in failing hearts³ and in atherosclerotic lesions.^4,5 The functional importance of TLR4 has subsequently been demonstrated by the attenuated vascular inflammation and reduced lesion size in TLR4-deficient atherosclerosis prone mice,⁶ and by the association of hyporesponsive TLR4 variants with disease development.^7,8 Furthermore, excessive activation of TLR4 by LPS induces endotoxin shock, a serious systemic disorder with a high mortality rate. Therefore TLR signaling must be tightly controlled to avoid improper activation or suppression. Yet regulation of TLR4 expression in cardiovascular disease remains elusive. In the current issue of Arteriosclerosis, Thrombosis, and Vascular Biology, two sister papers by Feng-Yen Lin and colleagues^9,10 lend new mechanistic insights that oxidative stress induces posttranscriptional stabilization of TLR4 mRNA in vascular cells.

See pages 2622 and 2630

Posttranscriptional regulation of mRNA stability is a . . . [Full Text of this Article]

Related Articles:

The Role of Human Antigen R, an RNA-binding Protein, in Mediating the Stabilization of Toll-Like Receptor 4 mRNA Induced by Endotoxin: A Novel Mechanism Involved in Vascular Inflammation

Feng-Yen Lin, Yung-Hsiang Chen, Yi-Wen Lin, Jen-Sung Tsai, Jaw-Wen Chen, Hsiao-Jung Wang, Yuh-Lien Chen, Chi-Yuan Li, and Shing-Jong Lin
Arterioscler Thromb Vasc Biol 2006 26: 2622-2629. [Abstract] [Full Text] [PDF]

Endotoxin Induces Toll-Like Receptor 4 Expression in Vascular Smooth Muscle Cells via NADPH Oxidase Activation and Mitogen-Activated Protein Kinase Signaling Pathways

Feng-Yen Lin, Yung-Hsiang Chen, Jen-Sung Tasi, Jaw-Wen Chen, Tung-Lin Yang, Hsiao-Jung Wang, Chi-Yuan Li, Yuh-Lien Chen, and Shing-Jong Lin
Arterioscler Thromb Vasc Biol 2006 26: 2630-2637. [Abstract] [Full Text] [PDF]